Wednesday, Jan. 18, 2023 Probiotic Markedly Reduces S. aureus Colonization in Phase 2 trial This image shows methicillin-resistant Staphylococcus aureus bacteria (yellow) being ingested by a neutrophil (purplish blue). Credit: NIAID NIAID scientists and colleagues in Thailand have found that a probiotic was safe and effective at controlling Staphylococcus aureus bacterial colonization in people, highlighting a promising alternative approach to using antibiotics. The Phase 2 trial, involving 115 people, resulted in a 96.8% S. aureus reduction in the stool and a 65.4% reduction in the nose. Importantly, the researchers found that the probiotic used, Bacillus subtilis, did not harm the gut microbiota while markedly reducing S. aureus colonization in trial participants. The microbiota includes the trillions of beneficial microbes living harmoniously on our skin and inside our gut. The study is published in The Lancet Microbe. The researchers plan to continue their work by testing the probiotic in a larger and longer trial. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107